Clinical Trials Logo

Infant Botulism clinical trials

View clinical trials related to Infant Botulism.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00004401 Completed - Botulism Clinical Trials

Study of Human Botulism Immunoglobulin in Infants With Botulism

Start date: January 1998
Phase: N/A
Study type: Interventional

OBJECTIVES: I. Determine the safety of human botulism immune globulin (BIG) in patients with infant botulism by monitoring side effects (e.g., rash, fever, hypotension, and anaphylaxis). II. Assess the efficacy of BIG in these patients by monitoring disease severity, incidence of complications (respiratory arrest, aspiration, pneumonia, etc.), and length of hospital stay.